Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $157.52 million. The enterprise value is $150.34 million.

Market Cap	157.52M
Enterprise Value	150.34M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ELTX has 16.32 million shares outstanding. The number of shares has increased by 45.99% in one year.

Current Share Class	16.32M
Shares Outstanding	16.32M
Shares Change (YoY)	+45.99%
Shares Change (QoQ)	+24.01%
Owned by Insiders (%)	34.82%
Owned by Institutions (%)	18.54%
Float	10.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	85.57
P/TBV Ratio	85.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.28, with a Debt / Equity ratio of 8.13.

Current Ratio	2.28
Quick Ratio	2.23
Debt / Equity	8.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-60.34

Financial Efficiency

Return on equity (ROE) is -60,013.19% and return on invested capital (ROIC) is -259.55%.

Return on Equity (ROE)	-60,013.19%
Return on Assets (ROA)	-123.26%
Return on Invested Capital (ROIC)	-259.55%
Return on Capital Employed (ROCE)	-227.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.71M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +123.38% in the last 52 weeks. The beta is 2.15, so ELTX's price volatility has been higher than the market average.

Beta (5Y)	2.15
52-Week Price Change	+123.38%
50-Day Moving Average	8.67
200-Day Moving Average	6.84
Relative Strength Index (RSI)	56.87
Average Volume (20 Days)	56,491

Short Selling Information

The latest short interest is 416,956, so 2.55% of the outstanding shares have been sold short.

Short Interest	416,956
Short Previous Month	411,360
Short % of Shares Out	2.55%
Short % of Float	3.92%
Short Ratio (days to cover)	11.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.65M
Pretax Income	-38.99M
Net Income	-54.61M
EBITDA	-44.38M
EBIT	-44.65M
Earnings Per Share (EPS)	-$3.88

Full Income Statement

Balance Sheet

The company has $22.09 million in cash and $14.90 million in debt, giving a net cash position of $7.19 million or $0.44 per share.

Cash & Cash Equivalents	22.09M
Total Debt	14.90M
Net Cash	7.19M
Net Cash Per Share	$0.44
Equity (Book Value)	1.83M
Book Value Per Share	0.11
Working Capital	12.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.09 million and capital expenditures -$45,000, giving a free cash flow of -$35.13 million.

Operating Cash Flow	-35.09M
Capital Expenditures	-45,000
Free Cash Flow	-35.13M
FCF Per Share	-$2.15

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-45.99%
Shareholder Yield	-45.99%
Earnings Yield	-34.67%
FCF Yield	-22.30%

Analyst Forecast

The average price target for ELTX is $11.00, which is 13.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	13.99%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-26.60%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2